Rockbridge Investment Management, Lcc Exact Sciences Corp Transaction History

Rockbridge Investment Management, Lcc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $10,394 - $13,326	176 Added 733.33%	200 $14.8 Million
Q3 2022 May 28, 2024	SELL	$31.97 - $49.37 $767 - $1,184	-24 Closed	0 $0
Q1 2022 May 28, 2024	BUY	$57.56 - $82.54 $1,381 - $1,980	24 New	24 $1,000
Q1 2021 May 20, 2021	SELL	$116.57 - $155.01 $1,282 - $1,705	-11 Reduced 31.43%	24 $3,000
Q2 2020 Aug 20, 2020	BUY	$55.75 - $92.75 $1,951 - $3,246	35 New	35 $3,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.